Suppression of NLRP3 inflammasome by γ -tocotrienol ameliorates type 2 diabetes

Yongeun Kim, Wei Wang, Meshail Okla, Inhae Kang, Regis Moreau, Soonkyu Chung

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The Nod-like receptor 3 (NLRP3) inflammasome is an intracellular sensor that sets off the innate immune system in response to microbial-derived and endogenous metabolic danger signals. We previously reported that γ -tocotrienol (γT3) attenuated adipose tissue infl ammation and insulin resistance in diet-induced obesity, but the underlying mechanism remained elusive. Here, we investigated the effects of γT3 on NLRP3 inflammasome activation and attendant consequences on type 2 diabetes. γT3 repressed inflammasome activation, caspase-1 cleavage, and interleukin (IL) 1β secretion in murine macrophages, implicating the inhibition of NLRP3 inflammasome in the anti-inflammatory and antipyroptotic properties of γT3. Furthermore, supplementation of leptin-receptor KO mice with γT3 attenuated immune cell infi ltration into adipose tissue, decreased circulating IL-18 levels, preserved pancreatic β-cells, and improved insulin sensitivity. Mechanistically, γT3 regulated the NLRP3 inflammasome via a two-pronged mechanism: 1 ) the induction of A20/TNF-α interacting protein 3 leading to the inhibition of the TNF receptor-associated factor 6/nuclear factor κB pathway and 2 ) the activation of AMP-activated protein kinase/autophagy axis leading to the attenuation of caspase-1 cleavage. Collectively, we demonstrated, for the fi rst time, that γT3 inhibits the NLRP3 inflammasome thereby delaying the progression of type 2 diabetes. This study also provides an insight into the novel therapeutic values of γT3 for treating NLRP3 inflammasome-associated chronic diseases.

Original languageEnglish (US)
Pages (from-to)66-76
Number of pages11
JournalJournal of Lipid Research
Volume57
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Tocotrienols
Inflammasomes
Medical problems
Type 2 Diabetes Mellitus
Caspase 1
Chemical activation
Insulin Resistance
Adipose Tissue
TNF Receptor-Associated Factor 6
Insulin
Tissue
Leptin Receptors
AMP-Activated Protein Kinases
Interleukin-18
Macrophages
Immune system
Autophagy
Nutrition
Interleukin-1
Immune System

Keywords

  • A20
  • Caspase 1
  • Diet and dietary lipids
  • Inflammation
  • Insulin signaling
  • NOD-like receptor protein 3
  • Obesity
  • Vitamin E

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Suppression of NLRP3 inflammasome by γ -tocotrienol ameliorates type 2 diabetes. / Kim, Yongeun; Wang, Wei; Okla, Meshail; Kang, Inhae; Moreau, Regis; Chung, Soonkyu.

In: Journal of Lipid Research, Vol. 57, No. 1, 01.01.2016, p. 66-76.

Research output: Contribution to journalArticle

Kim, Yongeun ; Wang, Wei ; Okla, Meshail ; Kang, Inhae ; Moreau, Regis ; Chung, Soonkyu. / Suppression of NLRP3 inflammasome by γ -tocotrienol ameliorates type 2 diabetes. In: Journal of Lipid Research. 2016 ; Vol. 57, No. 1. pp. 66-76.
@article{44a7e103531f43d78d556da8ddf15ee5,
title = "Suppression of NLRP3 inflammasome by γ -tocotrienol ameliorates type 2 diabetes",
abstract = "The Nod-like receptor 3 (NLRP3) inflammasome is an intracellular sensor that sets off the innate immune system in response to microbial-derived and endogenous metabolic danger signals. We previously reported that γ -tocotrienol (γT3) attenuated adipose tissue infl ammation and insulin resistance in diet-induced obesity, but the underlying mechanism remained elusive. Here, we investigated the effects of γT3 on NLRP3 inflammasome activation and attendant consequences on type 2 diabetes. γT3 repressed inflammasome activation, caspase-1 cleavage, and interleukin (IL) 1β secretion in murine macrophages, implicating the inhibition of NLRP3 inflammasome in the anti-inflammatory and antipyroptotic properties of γT3. Furthermore, supplementation of leptin-receptor KO mice with γT3 attenuated immune cell infi ltration into adipose tissue, decreased circulating IL-18 levels, preserved pancreatic β-cells, and improved insulin sensitivity. Mechanistically, γT3 regulated the NLRP3 inflammasome via a two-pronged mechanism: 1 ) the induction of A20/TNF-α interacting protein 3 leading to the inhibition of the TNF receptor-associated factor 6/nuclear factor κB pathway and 2 ) the activation of AMP-activated protein kinase/autophagy axis leading to the attenuation of caspase-1 cleavage. Collectively, we demonstrated, for the fi rst time, that γT3 inhibits the NLRP3 inflammasome thereby delaying the progression of type 2 diabetes. This study also provides an insight into the novel therapeutic values of γT3 for treating NLRP3 inflammasome-associated chronic diseases.",
keywords = "A20, Caspase 1, Diet and dietary lipids, Inflammation, Insulin signaling, NOD-like receptor protein 3, Obesity, Vitamin E",
author = "Yongeun Kim and Wei Wang and Meshail Okla and Inhae Kang and Regis Moreau and Soonkyu Chung",
year = "2016",
month = "1",
day = "1",
doi = "10.1194/jlr.M062828",
language = "English (US)",
volume = "57",
pages = "66--76",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "1",

}

TY - JOUR

T1 - Suppression of NLRP3 inflammasome by γ -tocotrienol ameliorates type 2 diabetes

AU - Kim, Yongeun

AU - Wang, Wei

AU - Okla, Meshail

AU - Kang, Inhae

AU - Moreau, Regis

AU - Chung, Soonkyu

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The Nod-like receptor 3 (NLRP3) inflammasome is an intracellular sensor that sets off the innate immune system in response to microbial-derived and endogenous metabolic danger signals. We previously reported that γ -tocotrienol (γT3) attenuated adipose tissue infl ammation and insulin resistance in diet-induced obesity, but the underlying mechanism remained elusive. Here, we investigated the effects of γT3 on NLRP3 inflammasome activation and attendant consequences on type 2 diabetes. γT3 repressed inflammasome activation, caspase-1 cleavage, and interleukin (IL) 1β secretion in murine macrophages, implicating the inhibition of NLRP3 inflammasome in the anti-inflammatory and antipyroptotic properties of γT3. Furthermore, supplementation of leptin-receptor KO mice with γT3 attenuated immune cell infi ltration into adipose tissue, decreased circulating IL-18 levels, preserved pancreatic β-cells, and improved insulin sensitivity. Mechanistically, γT3 regulated the NLRP3 inflammasome via a two-pronged mechanism: 1 ) the induction of A20/TNF-α interacting protein 3 leading to the inhibition of the TNF receptor-associated factor 6/nuclear factor κB pathway and 2 ) the activation of AMP-activated protein kinase/autophagy axis leading to the attenuation of caspase-1 cleavage. Collectively, we demonstrated, for the fi rst time, that γT3 inhibits the NLRP3 inflammasome thereby delaying the progression of type 2 diabetes. This study also provides an insight into the novel therapeutic values of γT3 for treating NLRP3 inflammasome-associated chronic diseases.

AB - The Nod-like receptor 3 (NLRP3) inflammasome is an intracellular sensor that sets off the innate immune system in response to microbial-derived and endogenous metabolic danger signals. We previously reported that γ -tocotrienol (γT3) attenuated adipose tissue infl ammation and insulin resistance in diet-induced obesity, but the underlying mechanism remained elusive. Here, we investigated the effects of γT3 on NLRP3 inflammasome activation and attendant consequences on type 2 diabetes. γT3 repressed inflammasome activation, caspase-1 cleavage, and interleukin (IL) 1β secretion in murine macrophages, implicating the inhibition of NLRP3 inflammasome in the anti-inflammatory and antipyroptotic properties of γT3. Furthermore, supplementation of leptin-receptor KO mice with γT3 attenuated immune cell infi ltration into adipose tissue, decreased circulating IL-18 levels, preserved pancreatic β-cells, and improved insulin sensitivity. Mechanistically, γT3 regulated the NLRP3 inflammasome via a two-pronged mechanism: 1 ) the induction of A20/TNF-α interacting protein 3 leading to the inhibition of the TNF receptor-associated factor 6/nuclear factor κB pathway and 2 ) the activation of AMP-activated protein kinase/autophagy axis leading to the attenuation of caspase-1 cleavage. Collectively, we demonstrated, for the fi rst time, that γT3 inhibits the NLRP3 inflammasome thereby delaying the progression of type 2 diabetes. This study also provides an insight into the novel therapeutic values of γT3 for treating NLRP3 inflammasome-associated chronic diseases.

KW - A20

KW - Caspase 1

KW - Diet and dietary lipids

KW - Inflammation

KW - Insulin signaling

KW - NOD-like receptor protein 3

KW - Obesity

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=84957309462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957309462&partnerID=8YFLogxK

U2 - 10.1194/jlr.M062828

DO - 10.1194/jlr.M062828

M3 - Article

C2 - 26628639

AN - SCOPUS:84957309462

VL - 57

SP - 66

EP - 76

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 1

ER -